Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only. [electronic resource]
Producer: 20111017Description: 299-302 p. digitalISSN:- 1399-3062
- Adenine -- analogs & derivatives
- Antiviral Agents -- pharmacology
- Combined Modality Therapy
- Drug Resistance, Viral
- Guanine -- analogs & derivatives
- Hepatitis B -- drug therapy
- Hepatitis B virus -- drug effects
- Humans
- Immunization, Passive
- Immunoglobulins -- therapeutic use
- Lamivudine -- pharmacology
- Liver Transplantation -- adverse effects
- Male
- Middle Aged
- Organophosphonates -- therapeutic use
- Perioperative Care
- Secondary Prevention
- Tenofovir
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.